MCK

McKesson Corporation
HealthcareMedical DistributionNASDAQ
$742.44
-$23.30 (-3.14%)today
Conviction
0/ 10
Fair Value$995
Upside+34.02%
Signal0
Market Cap$106.8B
52W Range$637–$999
Next EarningsMay 7

Price History

Quick Take

McKesson Corporation provides healthcare services in the United States and internationally.

Trailing P/E24.7x
Forward P/E19.3x
P/S0.3x
EPS (TTM)$34.66
Analyst Target$995
Analyst Upside34.0%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10qMar 1
Conviction: unchanged
MCK Q3 FY2026 10-Q: Oncology Platform Buildout Driving EPS Acceleration

Revenue +15% YTD to B; diluted EPS +57% YTD to .73. North American Pharma (+13% rev, +39% op profit) and Oncology & Multispecialty (+30% rev, +54% op profit) carrying the story. Two major oncology acq...